- Home
- ATYR vs MRT Comparison
ATYR vs MRT Comparison
Compare ATYR & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | MRT |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | Turkey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Rental/Leasing Companies |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 175.5M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATYR | MRT |
|---|---|---|
| Price | $0.73 | $2.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $8.75 | $6.00 |
| AVG Volume (30 Days) | ★ 2.1M | 21.0K |
| Earning Date | 11-06-2025 | 08-08-2018 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $190,000.00 | ★ $24,577,378.00 |
| Revenue This Year | N/A | $84.11 |
| Revenue Next Year | $18,728.88 | $118.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 29.67 |
| 52 Week Low | $0.64 | $1.97 |
| 52 Week High | $7.29 | $3.89 |
Technical Indicators
Market Signals| Indicator | ATYR | MRT |
|---|---|---|
| Relative Strength Index (RSI) | 43.06 | 51.03 |
| Support Level | $0.69 | $2.16 |
| Resistance Level | $0.76 | $2.41 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 29.82 | 66.28 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure.